tirzepatide diabetes prevention Tirzepatide: 3-Year Weight Loss & Study | PDF | Human Diseases And Disorders How the weight loss drug

S.NarayanaswamiV.RyanR

This information will be valuable for healthcare professionals managing your care and for adjusting your future treatment plan

The SURMOUNT-1 trial enrolled 2,539 patients with obesity, excluding individuals with diabetes or uncontrolled hypertension, and randomized them to placebo or 5, 10, or 15 mg of tirzepatide

If you feel symptoms improve in that 15 minutes, then its time to switch to a balanced snack

Phase 2 trials documented average weight loss of 24.2% at the 12mg dose over 48 weeks, surpassing anything previously achieved through pharmaceutical intervention alone

Inform your provider about the switch so they can update your records